Evidence map›Paper›PMID 36261377›Full record

ArticleInternal medicine (Tokyo, Japan)2023

Rapid Progression of Autoimmune Gastritis after Helicobacter pylori Eradication Therapy.

Takashi Ihara, Noriko Ihara, Ryoji Kushima, Ken Haruma

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Special Issue: Molecular Advances inInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Article
  6. Gyrus-like endoscopic changes in autoimmune gastritis with pastWorld journal of gastrointestinal endoscopy · 2025
    Article
  7. Article
  8. Autoimmune Gastritis andInternational journal of molecular sciences · 2025
    Review
  9. Gastric cancer in patients withWorld journal of gastrointestinal oncology · 2025
    Article
  10. Article
  11. Review
  12. Arising of autoimmune gastritis afterOxford medical case reports · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Takashi IharaIhara Clinic of Internal Medicine, Japan.
Noriko IharaIhara Clinic of Internal Medicine, Japan.
Ryoji KushimaDepartment of Pathology, Shiga University of Medical Science, Japan.
Ken HarumaDepartment of General Internal Medicine 2, Kawasaki Medical School General Medical Center, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a case of autoimmune gastritis (AIG) with rapid progression after Helicobacter pylori eradication therapy. The patient's previous gastritis had followed the course of type B gastritis before eradication therapy for many years. Immediately after eradication, we diagnosed her with AIG and carefully followed changes in the endoscopic and histopathological findings and serum markers. All of these clinical findings showed significant atrophic progression in the corporal area for approximately three years. We concluded that H. pylori eradication therapy exacerbated AIG in this case.

Indexed as

GastritisGastritis, AtrophicHelicobacter InfectionsHelicobacter pyloriAtrophyFemaleHumansatrophic gastritisautoimmune gastritiseradication therapyHelicobacter pyloripepsinogentype B gastritis

Identifiers

PMID36261377
PMCPMC10292996

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.